Expert Outlines Collaborative Integrative Oncology Plans in Kidney Cancer

Article

Collaboration in kidney cancer palliative care and integrative medicine programs underscores the current development of University Hospitals’ integrative oncology wing.

Santosh Rao, MD, spoke with CancerNetwork® during Kidney Cancer Awareness Month 2023 about plans to expand University Hospitals Connor Whole Health, the integrative oncology wing of University Hospitals that will help to provide several types of clinical services to patients with cancer, including kidney cancer. This includes everything from acupuncture and massage to art therapy and meditation.

Rao, medical director of integrative oncology for University Hospitals Connor Whole Health and president-elect for the Society for Integrative Oncology, emphasized the collaborative nature of providing integrative care for patients at his institution. In terms of strategy, he noted a “synergy” among the different experts in supportive oncology, palliative care, and integrative oncology who all work together to improve inpatient and outpatient care, referral patterns, and symptom management for those receiving treatment at Connor Whole Health.

Transcript:

We’re building our integrative oncology program. Our integrative oncology program is part of University Hospitals, but it’s under a program called University Hospitals Connor Whole Health. And this is a whole wing of University Hospital Health that is responsible for integrative medicine as a whole. We work very closely with supportive oncology and palliative care, and we have a lot of strategies on how we can work together both on the inpatient and outpatient side.

A lot of these things are plans at this point. As of now, a lot of it is just collaboration between the different programs. But there’s a lot of synergy in many places around the world with palliative care, integrative medicine, and integrative oncology. We plan to pattern ourselves after that, some of which will happen in the hospital, where we really plan to offer complementary therapies alongside supportive oncology to help our patients with pain and other symptoms. And then we’ll try to do some of that on the outpatient side, as well, and to have referrals that make sense for some of the patients who have symptoms.

Reference

Integrative Health Services for Well-Being and Healing. University Hospitals Connor Whole Health. Accessed April 7, 2023. http://bit.ly/3zIRixi

Related Videos
The use of CT scans may help practices adaptively plan and adjust radiotherapy courses for patients with non–small cell lung cancer.
Patients with NSCLC who have comorbidities or frailty may also be able to receive treatment with fewer toxicities via proton beam radiotherapy.
Terrence T. Sio, MD, MS, emphasizes multidisciplinary collaboration for treating patients with NSCLC who may require more than 1 type of therapy.
Collaboration among nurses, social workers, and others may help in safely administering outpatient bispecific T-cell engager therapy to patients.
Immunotherapy may be an “elegant” method of managing colorectal cancer, says Gregory Charak, MD.
D. Ross Camidge, MD, PhD, spoke about how the approval of alectinib is the beginning of multiple other approvals for patients with ALK-positive NSCLC.
Nurses should be educated on cranial nerve impairment that may affect those with multiple myeloma who receive cilta-cel, says Leslie Bennett, MSN, RN.
Treatment with cilta-cel may give patients with multiple myeloma “more time,” according to Ishmael Applewhite, BSN, RN-BC, OCN.
Nurses may need to help patients with multiple myeloma adjust to walking differently in the event of peripheral neuropathy following cilta-cel.
Administering neoadjuvant therapy to patients with colorectal cancer may help surgical oncologists attain a negative-margin resection.
Related Content